This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Analysts' Actions: BIIB FSLR GOOG LNKD

Verisign (VRSN) was downgraded at Credit Suisse from outperform to neutral. $42.50 price target. Risk/reward is more balanced at current levels, Credit Suisse said.

Bio-Rad Laboratories (BIO) target was raised at Jefferies. Shares are now seen reaching $140. Strong fourth-quarter result, Jefferies said. Buy rating.

Darden Restaurants (DRI) numbers were lowered at Jefferies. Shares are now seen reaching $42. Estimates were also lowered on analyst meeting preannouncement, Jefferies said. Hold rating.

Expeditors International (EXPD) numbers were lowered at Jefferies. Shares are now seen reaching $44. Estimates were also lowered on earnings miss, Jefferies said. Buy rating.

Home Depot (HD) numbers were raised at UBS. Shares are now seen reaching $75. Estimates were also increased on strong execution, market share gains and good sector backdrop, UBS said. Buy rating.

Home Depot numbers were raised at Jefferies. Shares are now seen reaching $64. Estimates were also raised on share gains widening in the fourth quarter. Hold rating.

JPMorgan (JPM) estimates, price target were raised at BofA/Merrill. Shares are now seen reaching $55, according to Bank of America/Merrill Lynch. Estimates were also increased, as the company should see better net interest income and reserve releases, BofA/Merrill said. Buy rating.

Macy's (M) estimates were raised at UBS. Guidance points to accelerating FCF and expanding ROIC story. Neutral rating.

Priceline.com (PCLN) estimates, target were boosted at Benchmark. Shares are now seen reaching $800. Estimates were also increased, given accelerating international growth, Benchmark said. Buy rating.

Priceline.com target was raised at Jefferies. Shares are now seen reaching $820. Another solid quarter with some accelerating trends, Jefferies said. Buy rating.

Questcor Pharmaceuticals (QCOR) numbers were raised at Jefferies. Shares are now seen reaching $38. Estimates were also raised on strong fourth quarter with robust 2013 outlook, Jefferies said. Buy rating.

Vitamin Shoppe (VSI) numbers were reduced at Credit Suisse. Shares are now seen reaching $65. Estimates were also cut, as the company is facing cost headwinds, Credit Suisse said. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

Stock quotes in this article: GOOG, GRPN, JCP, CHTR, SKS 
This article was written by a staff member of TheStreet.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,431.59 +6.74 0.04%
S&P 500 1,867.69 +5.38 0.29%
NASDAQ 4,105.3480 +19.1230 0.47%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs